These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26503996)

  • 41. [Successful treatment of huge peritoneal metastasis from duodenal gastrointestinal stromal tumor resistant for imatinib mesylate].
    Sakakura C; Kumano T; Mizuta Y; Yamaoka N; Sagara Y; Hagiwara A; Otsuji E
    Gan To Kagaku Ryoho; 2007 Nov; 34(12):2144-6. PubMed ID: 18219926
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Understanding rechallenge and resistance in the tyrosine kinase inhibitor era: imatinib in gastrointestinal stromal tumor.
    Agulnik M; Giel JL
    Am J Clin Oncol; 2014 Aug; 37(4):417-22. PubMed ID: 22772433
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Imatinib in gastrointestinal stromal tumor treatment--results from University Hospital Centre Zagreb].
    Vrbanec D; Petricević B; Majerović M; Stern-Padovan R; Belev B; Skegro M; Herceg D; Plestina S; Dedić-Plavetić N; Jakić-Razumović J
    Lijec Vjesn; 2006; 128(5-6):161-6. PubMed ID: 16910417
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Gastrointestinal stromal tumor: 5 years later.
    van der Zwan SM; DeMatteo RP
    Cancer; 2005 Nov; 104(9):1781-8. PubMed ID: 16136600
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rhabdomyosarcomatous differentiation in gastrointestinal stromal tumors after tyrosine kinase inhibitor therapy: a novel form of tumor progression.
    Liegl B; Hornick JL; Antonescu CR; Corless CL; Fletcher CD
    Am J Surg Pathol; 2009 Feb; 33(2):218-26. PubMed ID: 18830121
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Similarities and differences in diagnosis and treatment of gastrointestinal stromal tumors between China, Japan and Korea: from expert consensus to cooperation prospect].
    Cao H; Wang M
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Sep; 22(9):812-819. PubMed ID: 31550818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Different factors are responsible for predicting relapses after primary tumors resection and for imatinib treatment outcomes in gastrointestinal stromal tumors.
    Rutkowski P; Debiec-Rychter M; Nowecki ZI; Wozniak A; Michej W; Limon J; Siedlecki JA; Jerzak Vel Dobosz A; Grzesiakowska U; Nasierowska-Guttmejer A; Sygut J; Nyckowski P; Krawczyk M; Ruka W
    Med Sci Monit; 2007 Nov; 13(11):CR515-522. PubMed ID: 17968300
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Medical treatment for gastrointestinal stromal tumor (GIST) in Japan].
    Sato A; Hamada K; Imataka H
    Gan To Kagaku Ryoho; 2012 May; 39(5):708-12. PubMed ID: 22584320
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Surgical resection of gastrointestinal stromal tumors after treatment with imatinib.
    Andtbacka RH; Ng CS; Scaife CL; Cormier JN; Hunt KK; Pisters PW; Pollock RE; Benjamin RS; Burgess MA; Chen LL; Trent J; Patel SR; Raymond K; Feig BW
    Ann Surg Oncol; 2007 Jan; 14(1):14-24. PubMed ID: 17072676
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Surgical intervention following imatinib treatment in patients with advanced gastrointestinal stromal tumors (GISTs).
    Sym SJ; Ryu MH; Lee JL; Chang HM; Kim TW; Kim HC; Kim KH; Yook JH; Kim BS; Kang YK
    J Surg Oncol; 2008 Jul; 98(1):27-33. PubMed ID: 18452195
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Current aspects of treatment in gastrointestinal stromal tumors (GIST)].
    Láng I; Hitre E
    Orv Hetil; 2005 May; 146(18 Suppl 1):935-41. PubMed ID: 15921308
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Gastrointestinal stromal tumors (GIST): a rare entity, a tumor model for personalized therapy, and yet ten different molecular subtypes.
    Blay JY; Le Cesne A; Cassier PA; Ray-Coquard IL
    Discov Med; 2012 May; 13(72):357-67. PubMed ID: 22642917
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The GOLD ReGISTry: a Global, Prospective, Observational Registry Collecting Longitudinal Data on Patients with Advanced and Localised Gastrointestinal Stromal Tumours.
    Barrios CH; Blackstein ME; Blay JY; Casali PG; Chacon M; Gu J; Kang YK; Nishida T; Purkayastha D; Woodman RC; Reichardt P
    Eur J Cancer; 2015 Nov; 51(16):2423-33. PubMed ID: 26248685
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Liver surgery in the multidisciplinary management of gastrointestinal stromal tumour.
    Cananzi FC; Belgaumkar AP; Lorenzi B; Mudan S
    ANZ J Surg; 2014 Dec; 84(12):E1-8. PubMed ID: 23647808
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gastrointestinal stromal tumors treatment in the Imatinib era. The role of fair indication.
    Vendettuoli M; Pironi D; Pontone S; Panarese A; La Gioia G; Arcieri S; Romani AM; Palazzini G; Filippini A
    Minerva Chir; 2012 Apr; 67(2):165-73. PubMed ID: 22487918
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nursing implications of imatinib as molecularly targeted therapy for gastrointestinal stromal tumors.
    Griffin JM; Amand MS; Demetri GD
    Clin J Oncol Nurs; 2005 Apr; 9(2):161-9. PubMed ID: 15853160
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Treatment of gastrointestinal stromal tumors with imatinib mesylate: a center-based study of 13 patients].
    Bar-Sela G; Lev LM; Kuten A; Wollner M; Haim N
    Harefuah; 2006 Jan; 145(1):2-7, 80. PubMed ID: 16450715
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cost-effectiveness of 3-years of adjuvant imatinib in gastrointestinal stromal tumors (GIST) in the United States.
    Sanon M; Taylor DC; Parthan A; Coombs J; Paolantonio M; Sasane M
    J Med Econ; 2013; 16(1):150-9. PubMed ID: 22762291
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Giant Esophageal GIST: Diagnostic and Therapeutic Challenge - Case Report.
    Constantinoiu S; Gheorghe M; Popa L; Ciocea C; Iosif C; Tiutiuca R; Iordache A; Cordoş I;
    Chirurgia (Bucur); 2015; 110(3):300-7. PubMed ID: 26158743
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Imatinib-induced agranulocytosis in patients with gastrointestinal stromal tumors.
    Farag S; Verschoor AJ; Bosma JW; Gelderblom H; Kerst JM; Sleijfer S; Steeghs N
    J Clin Pharmacol; 2015 Aug; 55(8):920-5. PubMed ID: 25810235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.